3309 Stock Overview
An investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and Mainland China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
C-MER Eye Care Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$3.23 |
| 52 Week High | HK$3.98 |
| 52 Week Low | HK$2.39 |
| Beta | 0.59 |
| 1 Month Change | 14.54% |
| 3 Month Change | 5.21% |
| 1 Year Change | n/a |
| 3 Year Change | -43.83% |
| 5 Year Change | -23.28% |
| Change since IPO | -6.65% |
Recent News & Updates
Recent updates
Shareholder Returns
| 3309 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | 1.9% | 1.4% | 2.6% |
| 1Y | n/a | -20.0% | 2.1% |
Return vs Industry: Insufficient data to determine how 3309 performed against the Hong Kong Healthcare industry.
Return vs Market: Insufficient data to determine how 3309 performed against the Hong Kong Market.
Price Volatility
| 3309 volatility | |
|---|---|
| 3309 Average Weekly Movement | 4.6% |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 15.7% |
| 10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 3309 has not had significant price volatility in the past 3 months.
Volatility Over Time: 3309's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 3,273 | Dennis Lam | www.cmereye.com |
C-MER Eye Care Holdings Limited, an investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and Mainland China. The company operates through four segments: HK Medical Business, Sales of Medical Consumables, Mainland China Ophthalmic Business, and Mainland China Dental Business. It provides dental, oncology, medical aesthetics, and laboratory services; and engages in the sale of vision aid products, such as glasses and lens, and medical consumables.
C-MER Eye Care Holdings Limited Fundamentals Summary
| 3309 fundamental statistics | |
|---|---|
| Market cap | HK$4.02b |
| Earnings (TTM) | HK$62.00m |
| Revenue (TTM) | HK$1.92b |
64.8x
P/E Ratio2.1x
P/S RatioIs 3309 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3309 income statement (TTM) | |
|---|---|
| Revenue | HK$1.92b |
| Cost of Revenue | HK$1.31b |
| Gross Profit | HK$618.96m |
| Other Expenses | HK$556.96m |
| Earnings | HK$62.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.05 |
| Gross Margin | 32.17% |
| Net Profit Margin | 3.22% |
| Debt/Equity Ratio | 1.2% |
How did 3309 perform over the long term?
See historical performance and comparison